サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1566928

吸収性フィブリンシーラントパッチ市場：用途別、エンドユーザー別：世界の機会分析と産業予測、2024年～2033年

Absorbable Fibrin Sealant Patch Market By Application , By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033

出版日
ページ情報
英文 228 Pages
納期
2～3営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
吸収性フィブリンシーラントパッチ市場：用途別、エンドユーザー別：世界の機会分析と産業予測、2024年～2033年
出版日: 2024年07月10日
発行: Allied Market Research
ページ情報: 英文 228 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

吸収性フィブリンシーラントパッチ市場

吸収性フィブリンシーラントパッチ市場は、2023年に3億米ドルと評価され、2024年から2033年にかけてCAGR 7.8%で成長し、2033年には7億米ドルに達すると予測されています。

吸収性フィブリンシーラントパッチは、出血を制御し、組織の治癒を促進するために外科処置で使用される無菌物体です。吸収性フィブリンシーラントパッチは、馬のコラーゲンスポンジとフィブリノーゲンおよびトロンビンからなる生分解性パッチです。パッチの製剤は、時間の経過とともに体内に吸収されるため、剥がす必要がなく、感染症のリスクも低減します。シーラントパッチは、従来のステープル留めや縫合では止血が困難であったり不十分であったりする手術の際に使用されることが多いです。

心臓血管、整形外科、および一般的な健康合併症の有病率の増加に起因する世界中の外科手術の実施における上昇は、吸収性フィブリンシーラントパッチ市場の主要な促進要因です。さらに、低侵襲手術の人気の急増は、それらが回復後の複雑さを排除するようにシーラントパッチの採用を後押ししています。新たな動向として、シーラントパッチは両面で同じように活性で効果的であり、牽引力を獲得しつつあります。従来のパッチと比較すると、新しいシーラントパッチは平均6倍の速さで、30分で出血が止まると報告されています。

しかし、シーラントパッチを使用する外科的処置のコストは、従来の外科的処置と比較してかなり高く、そのため、シーラントパッチを好まない人もいます。これが吸収性フィブリンシーラントパッチ市場の大きな抑制要因となっています。逆に、シーラントパッチの絶え間ない進歩は、市場拡大のための有利な機会を提示すると期待されています。英国の科学雑誌Natureに掲載された研究によると、次世代のパッチが設計されつつあり、瞬時の接着を提供し、迅速な光投影との互換性を持ち、治療薬を送達する可能性があると予測されています。

セグメントのレビュー

吸収性フィブリンシーラントパッチ市場は、用途、エンドユーザー、地域に区分されます。用途別では、一般外科、心臓血管外科、創傷管理、整形外科、泌尿器外科、眼科、その他に分けられます。エンドユーザー別では、病院＆クリニック、外来手術センター、その他に分類されます。地域別では、北米、欧州、アジア太平洋、LAMEAで分析されています。

主な調査結果

用途別では、その他セグメントが吸収性フィブリンシーラントパッチ市場を独占しています。

エンドユーザー別では、病院・診療所が高いシェアを占めています。

地域別では、北米が2033年までに最も高い収益を上げると予測されています。

本レポートはカスタマイズが可能です。

  • 規制ガイドライン
  • クライアントの関心に応じた企業プロファイルの追加
  • 国別または地域別の追加分析-市場規模と予測
  • 企業プロファイルの拡張リスト
  • 過去の市場データ
  • 主要プレーヤーの詳細（所在地、連絡先、サプライヤー／ベンダーネットワークなどを含む、エクセル形式）

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場情勢

  • 市場の定義と範囲
  • 主な調査結果
    • 主な投資機会
    • 主要成功戦略
  • ポーターのファイブフォース分析
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会

第4章 吸収性フィブリンシーラントパッチ市場：用途別

  • 市場概要
  • 一般外科
  • 心臓血管外科
  • 創傷管理
  • 整形外科
  • 泌尿器外科
  • 眼科外科
  • その他

第5章 吸収性フィブリンシーラントパッチ市場：エンドユーザー別

  • 市場概要
  • 病院および診療所
  • 外来手術センター
  • その他

第6章 吸収性フィブリンシーラントパッチ市場：地域別

  • 市場概要
  • 北米
    • 主な市場動向と機会
    • 米国の吸収性フィブリンシーラントパッチ市場
    • カナダの吸収性フィブリンシーラントパッチ市場
    • メキシコの吸収性フィブリンシーラントパッチ市場
  • 欧州
    • 主要市場動向と機会
    • ドイツの吸収性フィブリンシーラントパッチ市場
    • フランスの吸収性フィブリンシーラントパッチ市場
    • 英国の吸収性フィブリンシーラントパッチ市場
    • イタリアの吸収性フィブリンシーラントパッチ市場
    • スペインの吸収性フィブリンシーラントパッチの市場
    • その他欧州の吸収性フィブリンシーラントパッチ市場
  • アジア太平洋
    • 主な市場動向と機会
    • 日本の吸収性フィブリンシーラントパッチ市場
    • 中国吸収性フィブリンシーラントパッチ市場
    • インドの吸収性フィブリンシーラントパッチ市場
    • オーストラリアの吸収性フィブリンシーラントパッチ市場
    • 韓国の吸収性フィブリンシーラントパッチ市場
    • その他アジア太平洋の吸収性フィブリンシーラントパッチ市場
  • ラテンアメリカ・中東・アフリカ
    • 主な市場動向と機会
    • ブラジルの吸収性フィブリンシーラントパッチ市場
    • サウジアラビアの吸収性フィブリンシーラントパッチ市場
    • 南アフリカの吸収性フィブリンシーラントパッチ市場
    • その他のラテンアメリカ・中東・アフリカの吸収性フィブリンシーラントパッチ市場

第7章 競合情勢

  • イントロダクション
  • 主要成功戦略
  • 主要10社の製品マッピング
  • 競合ダッシュボード
  • 競合ヒートマップ
  • 主要企業のポジショニング（2023年）

第8章 企業プロファイル

  • Johnson And Johnson
  • Baxter International Inc
  • Takeda Pharmaceutical Company Limited
  • Becton, Dickinson And Company.
  • Corza Medical
  • LifeBond Ltd
  • Surgical Specialties Corporation
  • Biegler GmbH
  • Cohera Medical Inc
  • Integra LifeSciences Corporation
目次
Product Code: A323960

Absorbable Fibrin Sealant Patch Market

The absorbable fibrin sealant patch market was valued at $0.3 billion in 2023 and is projected to reach $0.7 billion by 2033, growing at a CAGR of 7.8% from 2024 to 2033.

An absorbable fibrin sealant patch is a sterile object used in surgical procedures to control bleeding and promote tissue healing. It is a biodegradable patch comprising of equine collagen sponge along with fibrinogen and thrombin, elements which are the key players in the natural blood clotting mechanism of the body. The formulation of the patch involves absorption by the body over time, hence eradicating the need for removal and reducing the risk of infections. The sealant patch is significantly administered during surgeries in which conventional stapling or suturing is difficult or insufficient for hemostasis.

Rise in the conduction of surgical procedures across the globe due to increase in prevalence of cardiovascular, orthopedic, and general health complications is a key driver of the absorbable fibrin sealant patch market. Moreover, surge in the popularity of minimally invasive operations is boosting the adoption of sealant patches as they eliminate the post-recovery intricacies. As an emerging trend, sealant patches that are equally active and effective on both sides are acquiring traction. When compared to the conventional patches, the new sealant patches are reported to be quick by an average of six times, ceasing bleeding in 30 minutes.

However, the cost of surgical procedures involving the use of sealant patches is significantly high as compared to the traditional surgeries, which deters several individuals from preferring them. This acts a major restraint for the absorbable fibrin sealant patch market. On the contrary, constant advancements in sealant patches are expected to present lucrative opportunities for market expansion. According to a study published in Nature, a British scientific journal, next generation of patches are being designed that are projected to provide instant adhesion, possess compatibility with rapid photo-projection, and have the potential to deliver therapeutics.

Segment Review

The absorbable fibrin sealant patch market is segmented into application, end user, and region. On the basis of application, the market is divided into general surgery, cardiovascular surgery, wound management, orthopedic surgery, urological surgery, ophthalmic surgery, and others. As per end user, it is classified into hospitals & clinics, ambulatory surgical centers, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of application, the others segment dominates the absorbable fibrin sealant patch market.

As per end user, the hospitals & clinics segment holds a high share of the market.

Region wise, North America is projected to be the highest revenue generator by 2033.

Competition Analysis

The major players operating in the global absorbable fibrin sealant patch market include Johnson & Johnson, Baxter International Inc, Takeda Pharmaceutical Company Limited, Becton, Dickinson and Company, Corza Medical, LifeBond Ltd, Surgical Specialties Corporation, Biegler GmbH, Cohera Medical Inc, and Integra LifeSciences Corporation. These players have adopted various key developmental strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Application

  • General Surgery
  • Cardiovascular Surgery
  • Wound Management
  • Orthopedic Surgery
  • Urological Surgery
  • Ophthalmic Surgery
  • Others

By End User

  • Hospitals and Clinics
  • Ambulatory Surgical Centers
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Johnson & Johnson
    • Baxter International Inc
    • Takeda Pharmaceutical Company Limited
    • Becton, Dickinson and Company.
    • Corza Medical
    • LifeBond Ltd
    • Surgical Specialties Corporation
    • Biegler GmbH
    • Cohera Medical Inc
    • Integra LifeSciences Corporation

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY APPLICATION

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Application
  • 4.2. General Surgery
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Cardiovascular Surgery
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country
  • 4.4. Wound Management
    • 4.4.1. Key Market Trends, Growth Factors and Opportunities
    • 4.4.2. Market Size and Forecast, By Region
    • 4.4.3. Market Share Analysis, By Country
  • 4.5. Orthopedic Surgery
    • 4.5.1. Key Market Trends, Growth Factors and Opportunities
    • 4.5.2. Market Size and Forecast, By Region
    • 4.5.3. Market Share Analysis, By Country
  • 4.6. Urological Surgery
    • 4.6.1. Key Market Trends, Growth Factors and Opportunities
    • 4.6.2. Market Size and Forecast, By Region
    • 4.6.3. Market Share Analysis, By Country
  • 4.7. Ophthalmic Surgery
    • 4.7.1. Key Market Trends, Growth Factors and Opportunities
    • 4.7.2. Market Size and Forecast, By Region
    • 4.7.3. Market Share Analysis, By Country
  • 4.8. Others
    • 4.8.1. Key Market Trends, Growth Factors and Opportunities
    • 4.8.2. Market Size and Forecast, By Region
    • 4.8.3. Market Share Analysis, By Country

CHAPTER 5: ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY END USER

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By End User
  • 5.2. Hospitals And Clinics
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Ambulatory Surgical Centers
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Others
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country

CHAPTER 6: ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY REGION

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By Region
  • 6.2. North America
    • 6.2.1. Key Market Trends and Opportunities
    • 6.2.2. Market Size and Forecast, By Application
    • 6.2.3. Market Size and Forecast, By End User
    • 6.2.4. Market Size and Forecast, By Country
    • 6.2.5. U.S. Absorbable Fibrin Sealant Patch Market
      • 6.2.5.1. Market Size and Forecast, By Application
      • 6.2.5.2. Market Size and Forecast, By End User
    • 6.2.6. Canada Absorbable Fibrin Sealant Patch Market
      • 6.2.6.1. Market Size and Forecast, By Application
      • 6.2.6.2. Market Size and Forecast, By End User
    • 6.2.7. Mexico Absorbable Fibrin Sealant Patch Market
      • 6.2.7.1. Market Size and Forecast, By Application
      • 6.2.7.2. Market Size and Forecast, By End User
  • 6.3. Europe
    • 6.3.1. Key Market Trends and Opportunities
    • 6.3.2. Market Size and Forecast, By Application
    • 6.3.3. Market Size and Forecast, By End User
    • 6.3.4. Market Size and Forecast, By Country
    • 6.3.5. Germany Absorbable Fibrin Sealant Patch Market
      • 6.3.5.1. Market Size and Forecast, By Application
      • 6.3.5.2. Market Size and Forecast, By End User
    • 6.3.6. France Absorbable Fibrin Sealant Patch Market
      • 6.3.6.1. Market Size and Forecast, By Application
      • 6.3.6.2. Market Size and Forecast, By End User
    • 6.3.7. UK Absorbable Fibrin Sealant Patch Market
      • 6.3.7.1. Market Size and Forecast, By Application
      • 6.3.7.2. Market Size and Forecast, By End User
    • 6.3.8. Italy Absorbable Fibrin Sealant Patch Market
      • 6.3.8.1. Market Size and Forecast, By Application
      • 6.3.8.2. Market Size and Forecast, By End User
    • 6.3.9. Spain Absorbable Fibrin Sealant Patch Market
      • 6.3.9.1. Market Size and Forecast, By Application
      • 6.3.9.2. Market Size and Forecast, By End User
    • 6.3.10. Rest of Europe Absorbable Fibrin Sealant Patch Market
      • 6.3.10.1. Market Size and Forecast, By Application
      • 6.3.10.2. Market Size and Forecast, By End User
  • 6.4. Asia-Pacific
    • 6.4.1. Key Market Trends and Opportunities
    • 6.4.2. Market Size and Forecast, By Application
    • 6.4.3. Market Size and Forecast, By End User
    • 6.4.4. Market Size and Forecast, By Country
    • 6.4.5. Japan Absorbable Fibrin Sealant Patch Market
      • 6.4.5.1. Market Size and Forecast, By Application
      • 6.4.5.2. Market Size and Forecast, By End User
    • 6.4.6. China Absorbable Fibrin Sealant Patch Market
      • 6.4.6.1. Market Size and Forecast, By Application
      • 6.4.6.2. Market Size and Forecast, By End User
    • 6.4.7. India Absorbable Fibrin Sealant Patch Market
      • 6.4.7.1. Market Size and Forecast, By Application
      • 6.4.7.2. Market Size and Forecast, By End User
    • 6.4.8. Australia Absorbable Fibrin Sealant Patch Market
      • 6.4.8.1. Market Size and Forecast, By Application
      • 6.4.8.2. Market Size and Forecast, By End User
    • 6.4.9. South Korea Absorbable Fibrin Sealant Patch Market
      • 6.4.9.1. Market Size and Forecast, By Application
      • 6.4.9.2. Market Size and Forecast, By End User
    • 6.4.10. Rest of Asia-Pacific Absorbable Fibrin Sealant Patch Market
      • 6.4.10.1. Market Size and Forecast, By Application
      • 6.4.10.2. Market Size and Forecast, By End User
  • 6.5. LAMEA
    • 6.5.1. Key Market Trends and Opportunities
    • 6.5.2. Market Size and Forecast, By Application
    • 6.5.3. Market Size and Forecast, By End User
    • 6.5.4. Market Size and Forecast, By Country
    • 6.5.5. Brazil Absorbable Fibrin Sealant Patch Market
      • 6.5.5.1. Market Size and Forecast, By Application
      • 6.5.5.2. Market Size and Forecast, By End User
    • 6.5.6. Saudi Arabia Absorbable Fibrin Sealant Patch Market
      • 6.5.6.1. Market Size and Forecast, By Application
      • 6.5.6.2. Market Size and Forecast, By End User
    • 6.5.7. South Africa Absorbable Fibrin Sealant Patch Market
      • 6.5.7.1. Market Size and Forecast, By Application
      • 6.5.7.2. Market Size and Forecast, By End User
    • 6.5.8. Rest of LAMEA Absorbable Fibrin Sealant Patch Market
      • 6.5.8.1. Market Size and Forecast, By Application
      • 6.5.8.2. Market Size and Forecast, By End User

CHAPTER 7: COMPETITIVE LANDSCAPE

  • 7.1. Introduction
  • 7.2. Top Winning Strategies
  • 7.3. Product Mapping of Top 10 Player
  • 7.4. Competitive Dashboard
  • 7.5. Competitive Heatmap
  • 7.6. Top Player Positioning, 2023

CHAPTER 8: COMPANY PROFILES

  • 8.1. Johnson And Johnson
    • 8.1.1. Company Overview
    • 8.1.2. Key Executives
    • 8.1.3. Company Snapshot
    • 8.1.4. Operating Business Segments
    • 8.1.5. Product Portfolio
    • 8.1.6. Business Performance
    • 8.1.7. Key Strategic Moves and Developments
  • 8.2. Baxter International Inc
    • 8.2.1. Company Overview
    • 8.2.2. Key Executives
    • 8.2.3. Company Snapshot
    • 8.2.4. Operating Business Segments
    • 8.2.5. Product Portfolio
    • 8.2.6. Business Performance
    • 8.2.7. Key Strategic Moves and Developments
  • 8.3. Takeda Pharmaceutical Company Limited
    • 8.3.1. Company Overview
    • 8.3.2. Key Executives
    • 8.3.3. Company Snapshot
    • 8.3.4. Operating Business Segments
    • 8.3.5. Product Portfolio
    • 8.3.6. Business Performance
    • 8.3.7. Key Strategic Moves and Developments
  • 8.4. Becton, Dickinson And Company.
    • 8.4.1. Company Overview
    • 8.4.2. Key Executives
    • 8.4.3. Company Snapshot
    • 8.4.4. Operating Business Segments
    • 8.4.5. Product Portfolio
    • 8.4.6. Business Performance
    • 8.4.7. Key Strategic Moves and Developments
  • 8.5. Corza Medical
    • 8.5.1. Company Overview
    • 8.5.2. Key Executives
    • 8.5.3. Company Snapshot
    • 8.5.4. Operating Business Segments
    • 8.5.5. Product Portfolio
    • 8.5.6. Business Performance
    • 8.5.7. Key Strategic Moves and Developments
  • 8.6. LifeBond Ltd
    • 8.6.1. Company Overview
    • 8.6.2. Key Executives
    • 8.6.3. Company Snapshot
    • 8.6.4. Operating Business Segments
    • 8.6.5. Product Portfolio
    • 8.6.6. Business Performance
    • 8.6.7. Key Strategic Moves and Developments
  • 8.7. Surgical Specialties Corporation
    • 8.7.1. Company Overview
    • 8.7.2. Key Executives
    • 8.7.3. Company Snapshot
    • 8.7.4. Operating Business Segments
    • 8.7.5. Product Portfolio
    • 8.7.6. Business Performance
    • 8.7.7. Key Strategic Moves and Developments
  • 8.8. Biegler GmbH
    • 8.8.1. Company Overview
    • 8.8.2. Key Executives
    • 8.8.3. Company Snapshot
    • 8.8.4. Operating Business Segments
    • 8.8.5. Product Portfolio
    • 8.8.6. Business Performance
    • 8.8.7. Key Strategic Moves and Developments
  • 8.9. Cohera Medical Inc
    • 8.9.1. Company Overview
    • 8.9.2. Key Executives
    • 8.9.3. Company Snapshot
    • 8.9.4. Operating Business Segments
    • 8.9.5. Product Portfolio
    • 8.9.6. Business Performance
    • 8.9.7. Key Strategic Moves and Developments
  • 8.10. Integra LifeSciences Corporation
    • 8.10.1. Company Overview
    • 8.10.2. Key Executives
    • 8.10.3. Company Snapshot
    • 8.10.4. Operating Business Segments
    • 8.10.5. Product Portfolio
    • 8.10.6. Business Performance
    • 8.10.7. Key Strategic Moves and Developments